Australian University Rankings Guide

Drug and Chemical Toxicology: an international journal for rapid communication (ERA Journal)

Drug and Chemical Toxicology: an international journal for rapid communication is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.

Drug and Chemical Toxicology: an international journal for rapid communication issns are issn1: 0148-0545 issn2: 1525-6014.

The field covered by Drug and Chemical Toxicology: an international journal for rapid communication as part of the evaluation of Australian university research excellence is:

Pharmacology and Pharmaceutical Sciences Research Rankings (Sub-Field)

Other ERA-accredited journals supporting the evaluation of the Pharmacology and Pharmaceutical Sciences field include:

- ACS Medicinal Chemistry Letters
- Birth Defects Research Part B: Developmental and Reproductive Toxicology
- Drug Discoveries and Therapeutics
- Drug Metabolism and Disposition
- European Journal of Clinical Pharmacology
- Expert Opinion on Therapeutic Targets
- Infectious Disorders: Drug Targets
- International Journal of Green Pharmacy
- Journal of Ocular Pharmacology and Therapeutics
- Journal of Pain Research
- Journal of Pain and Palliative Care Pharmacotherapy
- Journal of Young Pharmacists
- NeuroMolecular Medicine
- Pharmacoepidemiology and Drug Safety
- Phytochemistry Letters


ERA Research Rankings Submenu


- ERA 2018 Outcomes Research Rankings List

- ERA 2018 Research Rankings Analysis

- ERA 2018 Individual University Outcomes List

- ERA List of Research Fields Rankings

- ERA Journal Rankings 2018 List



Latest News and Updates:


- Top 10 Best Australian Universities

- Gender Balance Male-Female Ratio

- ERA 2018 Outcomes Research Rankings List

- University Bachelor Degree Completion Rates

- QS Employability Rankings Australian Universities

- ARWU World Rankings of Australian Universities

- Group of Eight (go8) World Rankings

Share This Page

  • Share on Facebook1
  • Share on Twitter2
  • Share on Linkedin3
  • Share on Reddit4